Case series:GLS-010

2 trials

Sponsors

Beijing Cancer Hosptical, Fudan University Shanghai Cancer Hospital

Conditions

classical Hodgkin's lymphomarecurrent or metastatic cervical cancer

Phase 2

Phase II study of GLS-010 injection in the treatment of classical Hodgkin's lymphoma

RecruitingChiCTR1800018042

Beijing Cancer Hospticalclassical Hodgkin's lymphoma

Start: 2018-08-29Updated: 2018-09-03

An open, multi-center, single-arm phase II clinical study for evaluating the efficacy and safety of recombinant fully human anti-PD-1 monoclonal antibody (GLS-010 injection) in patients with recurrent or metastatic cervical cancer

Active, not recruitingChiCTR1900023529

Fudan University Shanghai Cancer Hospitalrecurrent or metastatic cervical cancer

Start: 2019-06-01Updated: 2019-06-03